S&P 500 Futures
(-0.06%) 5 305.00 points
Dow J Futures
(0.00%) 40 143 points
Nasdaq Futures
(-0.10%) 18 485 points
Oil
(0.27%) $81.57
Gas
(-1.05%) $1.700
Gold
(0.04%) $2 213.50
Silver
(-0.91%) $24.53
Platinum
(-0.49%) $905.25
USD/EUR
(0.40%) $0.927
USD/NOK
(0.74%) $10.85
USD/GBP
(0.33%) $0.794
USD/RUB
(0.00%) $92.44

Realtime updates for Equillium Inc [EQ]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-03-28)

Expected move: +/- 9.38%

Last Updated27 Mar 2024 @ 16:00

0.00% $ 2.06

Live Chart Being Loaded With Signals

Commentary (27 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Equillium Inc

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need...

Stats
Today's Volume 170 545
Average Volume 368 490
Market Cap 72.62M
EPS $-0.110 ( 2023-11-08 )
Next earnings date ( $-0.160 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -9.36
ATR14 $0.0150 (0.72%)
Insider Trading
Date Person Action Amount type
2024-03-06 Tom Penny Sell 0 Common Stock
2024-03-06 Tom Penny Sell 45 000 Employee Stock Option (right to buy)
2024-03-06 Tom Penny Sell 40 000 Employee Stock Option (right to buy)
2024-03-06 Tom Penny Sell 60 000 Employee Stock Option (right to buy)
2024-03-06 Tom Penny Sell 40 000 Employee Stock Option (right to buy)
INSIDER POWER
62.54
Last 97 transactions
Buy: 3 858 069 | Sell: 577 250

Volume Correlation

Long: -0.07 (neutral)
Short: -0.78 (moderate negative)
Signal:(56.065) Neutral

Equillium Inc Correlation

10 Most Positive Correlations
GRNV0.919
EGRX0.917
AXTI0.917
VVOS0.915
FVE0.909
BCRX0.906
NVEE0.904
OTRK0.903
BFRI0.903
CNSP0.898
10 Most Negative Correlations
AMRB-0.94
LSTR-0.939
RMBS-0.937
LSCC-0.936
MCHP-0.932
KE-0.93
SNSR-0.926
SMH-0.923
SOXX-0.918
GRID-0.917

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Equillium Inc Correlation - Currency/Commodity

The country flag 0.38
( neutral )
The country flag 0.48
( neutral )
The country flag 0.00
( neutral )
The country flag -0.16
( neutral )
The country flag -0.68
( moderate negative )
The country flag 0.17
( neutral )

Equillium Inc Financials

Annual 2023
Revenue: $36.08M
Gross Profit: $36.08M (100.00 %)
EPS: $-0.380
Q4 2023
Revenue: $9.21M
Gross Profit: $9.21M (100.00 %)
EPS: $-0.0666
Q3 2023
Revenue: $8.87M
Gross Profit: $8.84M (99.65 %)
EPS: $-0.110
Q2 2023
Revenue: $9.12M
Gross Profit: $9.09M (99.66 %)
EPS: $-0.0970

Financial Reports:

No articles found.

Equillium Inc

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators